Dana Lucia Stanculeanu
Overview
Explore the profile of Dana Lucia Stanculeanu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mihaila R, Gheorghe A, Zob D, Stanculeanu D
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335659
: Immunotherapy has changed the therapeutic approach for various solid tumors, especially lung tumors, malignant melanoma, renal and urogenital carcinomas, demonstrating significant antitumor activity, with tolerable safety profiles and durable...
2.
Mihaila R, Gheorghe A, Zob D, Stanculeanu D
Cureus
. 2024 Sep;
16(9):e69301.
PMID: 39282490
Cutaneous malignant melanoma is one of the most aggressive forms of skin cancer and thus, a high mortality has been reported over decades. The prognosis for melanoma varies widely based...
3.
Afrasanie V, Rusu A, Gheorghe A, Froicu E, Dumitrescu E, Gafton B, et al.
Diagnostics (Basel)
. 2024 Sep;
14(17).
PMID: 39272683
Ovarian cancer is one of the most frequent malignancies in women. The treatment landscape underwent significant changes as new agents were introduced in ovarian cancer management over the last decade....
4.
Simion L, Petrescu I, Chitoran E, Rotaru V, Cirimbei C, Ionescu S, et al.
Life (Basel)
. 2024 Jan;
14(1).
PMID: 38255753
(1) Importance of problem: Breast cancer accounted for 685,000 deaths globally in 2020, and half of all cases occur in women with no specific risk factor besides gender and age...
5.
Tsantikidi A, Papazisis K, Floros T, Gazouli M, Papadopoulou E, Tsaousis G, et al.
Oncol Lett
. 2023 Oct;
26(5):480.
PMID: 37809048
Tumors harboring homologous recombination deficiency (HRD) are considered optimal candidates for poly(ADP-ribose) polymerase 1 (PARP) inhibitor treatment. Such deficiency can be detected by analyzing breast cancer type ( gene mutations,...
6.
Simion L, Ionescu S, Chitoran E, Rotaru V, Cirimbei C, Madge O, et al.
Medicina (Kaunas)
. 2023 Sep;
59(9).
PMID: 37763651
: Due to its many benefits, indocyanine green (ICG) has gained progressive popularity in operating rooms (ORs) globally. This literature review examines its qualitative and quantitative usage in surgical treatment....
7.
Simion L, Chitoran E, Cirimbei C, Stefan D, Neicu A, Tanase B, et al.
Diagnostics (Basel)
. 2023 Jun;
13(12).
PMID: 37370964
The aim of our study is to present the particularities of a specific subset of gynecological cancer patients in Romania. We present a review of synchronous gynecological neoplasia (SGN) treated...
8.
Radoi V, Turcan M, Maioru O, Dan A, Bohiltea L, Dumitrescu E, et al.
Diagnostics (Basel)
. 2023 Jun;
13(11).
PMID: 37296748
The Homologous Recombination Deficiency (HRD) Score, determined by evaluating genomic instability through the assessment of loss of heterozygosity (LOH), telomeric allelic imbalance (TAI), and large-scale state transitions (LST), serves as...
9.
Preda M, Tanase B, Zob D, Gheorghe A, Lungulescu C, Dumitrescu E, et al.
Int J Environ Res Public Health
. 2023 Jan;
20(2).
PMID: 36674038
Lung cancer and pulmonary tuberculosis are two significant public health problems that continue to take millions of lives each year. They may have similar symptoms and, in some cases, are...
10.
Gheorghe A, Dumitrescu E, Komporaly I, Mihaila R, Lungulescu C, Stanculeanu D
Curr Oncol
. 2022 Apr;
29(4):2835-2847.
PMID: 35448205
This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses...